英文名称 | 中文名称 | CAS | MF |
NA
|
|
|
|
NA
|
烷氧化四氢呋喃酸酯
|
|
|
NA
|
|
|
|
NA
|
高级单官能酯
|
|
|
NA
|
二丙二醇二丙烯酸酯(DPGDA)
|
|
|
NA
|
|
|
|
NA
|
|
|
|
NA
|
三(2-羟乙基)异氰尿酸三丙烯酸酯
|
|
|
NA
|
丙烯酸乙酯异氰酸酯
|
|
|
NA
|
甲基丙烯酸乙酯异氰酸酯
|
|
|
NA
|
|
|
|
NA
|
|
|
|
4-(1-PHENYL-2-(3-PHENYLUREIDO)ETHOXY)BENZO[B]THIOPHENE-2-CARBOXIMIDAMIDE
|
|
1057337-39-9
|
C24H22N4O2S
|
ETHYL 5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-3-CARBOXYLATE
|
|
1007473-53-1
|
C27H28N6O4
|
ETHYL 5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1-O-TOLYL-1H-PYRAZOLE-3-CARBOXYLATE
|
|
1007477-05-5
|
C29H31N5O4
|
n/a
|
|
|
|
NA
|
|
|
|
NA
|
|
|
|
NA
|
|
|
|
NA
|
|
|
|
ETHYL 1-(2-CHLOROPHENYL)-5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
|
|
1007483-08-0
|
C28H28ClN5O4
|
Pf-868554
|
|
877225-09-7
|
|
1-(4-(4-(5-Methyl-3-phenylisoxazole-4-carbonyl)piperazin-1-yl)phenyl)ethanone
|
|
941104-13-8
|
C23H23N3O3
|
4-(3-ethyl-5-Methylisoxazole-4-carbonyl)-1-(4-Methoxyphenyl)-6,6-diMethylpiperazin-2-one
|
|
1060929-26-1
|
C20H25N3O4
|
ETHYL 5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
|
|
1007477-89-5
|
C28H28FN5O4
|
NA
|
|
|
|
2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3S,4S)-
|
|
905854-03-7
|
C23H19N3O2
|
ETHYL 5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
|
|
1007477-32-8
|
C28H28FN5O4
|
1-PropanaMine, 3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-iMidazol-4-yl]phenoxy]-N,N-diethyl-
|
氯丁胶乳
|
603148-36-3
|
C32H38ClN3O2
|
Tivantinib (ARQ 197)
|
Tivantinib (ARQ 197)
|
905854-02-6
|
C23H19N3O2
|
Mk-2461 .
|
MK-2461
|
917879-39-1
|
C24H25N5O5S
|
ETHYL 5-(4-(4-(3,5-DIMETHYLISOXAZOLE-4-CARBONYL)PIPERAZIN-1-YL)PHENYL)-1-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
|
|
1007482-89-4
|
C29H31N5O5
|
cis-4-[4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]cyclohexaneacetic acid
|
顺式-4-[4-(4-氨基-7,7-二甲基-7H-嘧啶并[4,5-B][1,4]恶嗪-6-基)苯基]环己烷乙酸
|
701234-65-3
|
C22H26N4O3
|
NA
|
丙烯酸异癸酯
|
|
|
NA
|
|
|
|
NA
|
|
|
|
NA
|
低黏度三羟甲基丙烷三丙烯酸酯(TMPTA)
|
|
|
NA
|
聚乙二醇(1000)二甲基丙烯酸酯
|
|
|
NA
|
丙烯酸十三烷基酯
|
|
|
NA
|
烷氧化苯酚丙烯酸酯
|
|
|
NA
|
甲氧基聚乙二醇(550)单甲基
|
|
|
NA
|
二三羟甲基丙烷四丙烯酸酯
|
|
|
NA
|
丙烯酸十三酯
|
|
|
NA
|
甲基丙烯酸十四烷基酯
|
|
|
NA
|
(10)乙氧化双酚A二甲基丙烯酸酯
|
|
|
NA
|
|
|
|
NA
|
甲基丙烯酸十三酯
|
|
|
NA
|
(6)丙氧化三羟甲基丙烷三丙烯酸酯
|
|
|
Zimeldine
|
齐美定
|
|
|
Lymphocyte separation media
|
淋巴细胞分离液
|
|
|
TetrabutylAmmoniumhydroxide
|
四丁基氢氧化铵10%
|
|
|
Ginsenoside Rg2
|
人参皂甙RG2
|
|
|
NA
|
2-氟-5-碘苯甲腈
|
|
|
NA
|
邻苯二甲酸二异癸酯二异癸酯
|
|
|
NA
|
4-溴-3,5-二碘苯甲醛
|
|
|
NA
|
磷酸二苯基异丙苯酯
|
|
|
NA
|
加氢松香丙三醇酯
|
|
|
NA
|
3,4,5-三碘苯甲醛
|
|
|
NA
|
4-溴-3,5-二碘苯甲醇
|
|
|
N/A
|
|
|
|
NA
|
|
|
|
NA
|
|
|
|
NA
|
|
|
|
NA
|
|
|
|
PTMC
|
PTMC
|
|
|
difluoroethane
|
二氟乙烷
|
|
C2H4F2
|
Polyneopenthylglycoladipate
|
聚新戊二醇己二酸酯
|
|
|
N-Acetyl-2-naphthylamin
|
N-乙酰-2-萘胺
|
|
C12H11NO
|
2-chloro-1-1’-dimethylbiphenyl
|
2-氯-1-1'-二甲基联苯
|
|
|
NA
|
三环癸烷二甲醇二丙烯酸酯
|
|
|
NA
|
端羟基的丙烯酸二已内酯
|
|
|
NA
|
|
|
|
NA
|
高纯度丙烯酸十八烷基酯
|
|
|
NA
|
全氟辛磺酰氟
|
|
|
NA
|
二季戊四醇五/六丙烯酸酯
|
|
|
NA
|
(8)乙氧化双酚A二甲基丙烯酸酯
|
|
|
NA
|
月桂酯
|
|
|
NA
|
五丙烯酸酯
|
|
|
NA
|
|
|
|
NA
|
高纯度三羟甲基丙烷三丙烯酸酯
|
|
|
NA
|
|
|
|
NA
|
二缩三乙二醇二甲基丙烯酸酯
|
|
|
NA
|
丙烯酸正十二酯
|
|
|
NA
|
|
|
|
NA
|
(6)乙氧化三羟甲基丙烷三丙烯酸酯
|
|
|
3-chloro-4'-methoxy propiophenone
|
3-氯-4'-甲氟基苯丙酮
|
|
|
3-Chloro-6-fluorobenzaldehyde
|
3-氯-6-氟苯甲醛
|
|
|
NA
|
二环戊二烯甲基丙烯酸酯
|
|
|
NA
|
聚乙二醇(400)二甲基丙烯酸酯
|
|
|
NA
|
烷氧化脂肪族二丙烯酸酯
|
|
|
NA
|
三缩四乙二醇二甲基丙烯酸酯(TEGDMA)
|
|
|
NA
|
高纯度丙烯酸酯
|
|
|
NA
|
|
|
|
NA
|
丙烯酸异冰片酯(IBOA)
|
|
|
NA
|
(3)丙氧化三羟甲基丙烷三丙烯酸酯
|
|
|
NA
|
|
|
|
Sodium Stannate Trihydrate
|
锡酸钠
|
12009-98-2
|
Na2SnO3·3H2O
|
Thiophosphoric acid O,O-diethyl S-benzyl ester
|
S-苄基-O,O-二乙基硫代磷酸酯
|
13286-32-3
|
C11H17O3PS
|
NA
|
|
|
|
NA
|
|
|
|